45 references, page 1 of 3
1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35 Suppl 1:S64-S71. doi: 10.2337/dc12-s064.
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137--49, http://dx.doi.org/ 10.1016/j.diabres.2013.11.002 [OpenAIRE]
3. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam salud pu´ıblica=Pan Am J public Heal. 2001;10:300--8, http://dx.doi.org/ 10.1590/S1020-49892001001100002 [OpenAIRE]
4. Aschner P, Aguilar-Salinas C, Aguirre L, Franco L, Gagliardino J, Gorban S, et al. Diabetes in South and Central America: An update. Diabetes Res Clin Pract. 2014;103:238--43, http://dx.doi.org/10.1016/j.diabres.2013.11.010
5. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001:S14--21, http://dx.doi.org/10.1007/PL00002934, 44 Suppl 2(Suppl 2).
6. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio Jr, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245--50, http://dx.doi.org/10.1161/01.CIR. 0000140677.20606.0E
7. Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007;167:1145--51, http://dx.doi.org/10.1001/archinte.167.11.1145
8. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2--14, http://dx.doi.org/ 10.1161/01.ATV.11.1.2t
9. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937--52, http://dx.doi.org/10.1016/S0140-6736(04)17018-9 [OpenAIRE]
10. Airaksinen KE. Silent coronary artery disease in diabetes-a feature of autonomic neuropathy or accelerated atherosclerosis? Diabetologia. 2001;44:259--66, http://dx.doi.org/10.1007/s001250051609 [OpenAIRE]
11. Blanchet Deverly A, Amara M, Larifla L, VelayoudomCéphise FL, Roques F, Kangambega P, et al. Silent myocardial ischaemia and risk factors in a diabetic AfroCaribbean population. Diabetes Metab. 2011;37:533--9, http://dx.doi.org/10.1016/j.diabet.2011.05.006
12. Milan Study on Atherosclerosis and Diabetes (MiSAD). Prevalence of Unrecognized Silent Myocardial Ischemia and Its Association With Atherosclerotic Risk Factors in NoninsulinDependent Diabetes Mellitus. Am J Cardiol. 1997; 79(2):134-39. doi:10.1016/S0002-9149(96)00699-6.
13. Miller TD, Rajagopalan N, Hodge DO, Frye RL, Gibbons RJ. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J. 2004;147:890--6, http://dx.doi.org/10.1016/j.ahj.2003.08.015
14. Barthelemy O, Jacqueminet S, Rouzet F, Isnard R, Bouzamondo A, Le Guludec D, et al. Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes. Arch Cardiovasc Dis. 2008;101:539--46, http://dx.doi.org/10.1016/j.acvd.2008.06.015
15. IDF, Diabetes Atlas, Group. Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2013. Diabetes Res Clin Pract. 2015;109:461--5, http://dx.doi.org/10.1016/j.diabres.2015.05.037
45 references, page 1 of 3
Copyright policy)
Powered by OpenAIRE Research Graph